{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-22-010767","form_type":"8-K","ticker":"CVM","cik":"0000725363","company_name":"CEL SCI CORP","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.021867+00:00","generated_at":"2026-06-24T03:04:57.158696+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CEL-SCI appoints Gail K. Naughton, Ph.D. to Board of Directors","bullets":["Dr. Naughton founded Advanced Tissue Sciences (ATIS) and Histogen (HSTO), with 35+ years in regenerative medicine.","She holds over 125 U.S. and foreign patents and received the National Inventor of the Year award in 2000.","She serves on boards of Therapeutics MD (TXMD) and chairs the La Jolla Institute for Immunology board.","Appointment effective August 2, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-22-010767","json":"https://secwatch.observer/filing/0001654954-22-010767.json","markdown":"https://secwatch.observer/filing/0001654954-22-010767.md","text":"https://secwatch.observer/filing/0001654954-22-010767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/725363/000165495422010767/0001654954-22-010767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/725363/000165495422010767/cvm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:04:57.158696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"612f4dcfd9","claim":"Gail K. Naughton, Ph.D. was appointed as Director at CEL SCI CORP.","evidence_excerpt":"On August 2, 2022, CEL-SCI Corporation appointed Gail K. Naughton, Ph.D. to its Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/725363/000165495422010767/0001654954-22-010767-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}